Immport Therapeutics, Inc.
Publicly observedIrvine, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Irvine | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Immport Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | ZJAMPJY7M149 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant9 Sept 2026Publicly observed
NIH SBIR/STTR award: Identification of protective human monoclonal antibodies for passive immunization against Cryptosporidium
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant26 Aug 2026Publicly observed
NIH SBIR/STTR award: Discovery of Group A Streptococcus antigens for development of broadly effective vaccine candidates to prevent non-invasive and invasive disease and emergence of antimicrobial resistance
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant25 Aug 2025Publicly observed
NIH SBIR/STTR award: A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines
USD 292,254.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant25 Aug 2025Publicly observed
NIH SBIR/STTR award: A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Aug 2025Publicly observed
NIH SBIR/STTR award: Optimizing immunogenicity of novel Cryptosporidium vaccine candidates
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant12 Aug 2025Publicly observed
NIH SBIR/STTR award: Optimizing immunogenicity of novel Cryptosporidium vaccine candidates
USD 300,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.